Sen. Sheldon Whitehouse sold Amgen (AMGN)
Sen. Sheldon Whitehouse (D-RI) · $1K–$15K · traded Aug 12, 2026
Why this is a committee overlap
Whitehouse is a member of the Senate Committee on Finance, which oversees Drug Manufacturers companies. Amgen is classified in the Drug Manufacturers - General industry.
An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.
- Transaction
- Sold (partial)
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Aug 12, 2026
- Disclosed
- Sep 2, 2026
- Days to disclose
- 21
- Asset type
- Stock
- As filed
- Amgen Inc. - Common Stock
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- Sep 2, 2026$1K–$15K
Sold (partial) Lam Research LRCX
$1K–$15K · Traded Aug 13, 2026 · disclosed Sep 2, 2026 · Spouse
- Sep 2, 2026$1K–$15K
$1K–$15K · Traded Aug 13, 2026 · disclosed Sep 2, 2026 · Spouse
- Sep 2, 2026$15K–$50K
$15K–$50K · Traded Aug 13, 2026 · disclosed Sep 2, 2026
- Sep 2, 2026$1K–$15K
Sold (full) SDZNY- Sandoz Group AG ADR
$1K–$15K · Traded Aug 6, 2026 · disclosed Sep 2, 2026
Recent Congress trades in AMGN
- Nov 3, 2026$15K–$50K
Sen. Sheldon Whitehouse (D-RI)
$15K–$50K · Traded Oct 15, 2026 · disclosed Nov 3, 2026 · Spouse
Committee overlap: Finance - Oct 9, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 9, 2026 · Spouse
- Oct 2, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
$1K–$15K · Traded Sep 22, 2026 · disclosed Oct 2, 2026
- Sep 7, 2026$1K–$15K
- Aug 5, 2026$15K–$50K
Sen. Tommy Tuberville (R-AL)
$15K–$50K · Traded Apr 15, 2025 · disclosed Aug 5, 2026 · Joint · filed 477 days later
Committee overlap: HELP - Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 8, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jun 2, 2026 · disclosed Jul 8, 2026 · Dependent
- Jun 15, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
$1K–$15K · Traded Jun 5, 2026 · disclosed Jun 15, 2026
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.